Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

Meral Ulukoylu Menguc, Fatma Arikan, Pelin Aytan, Huseyin Saffet Bekoz, Fazıl Cagrı Hunutlu, Fatma Keklik Karadag, Gulcin Miyase Sonmez, Burak Deveci, Fatma Aykac, Ayse Uysal, Bugse Gulec Zengin, Turhan Koksal, Hulya Odluyurt, Deniz Goren, Turgay Ulas, Emel Isleyen, Esra Terzi Demirsoy, Metban Mastanzade, Selin Kucukyurt, Figen Atalay, Esin Oguz Kozan, Sureyya Yigit Kaya, Vildan Ozkocaman, Zehra Aksit Bozkına, Selami Koçak Toprak, Mustafa Cabuk, Volkan Karakus, Umut Yilmaz, Muhlis Cem Ar, Mehmet Sonmez, Melda Comert, Gulsum Ozet, Ozgur Mehtap, Mustafa Nuri Yenerel, Ahmet Kursad Gunes, Ayse Tulin Tuglular, Fahir Ozkalemkas, Güray Saydam, Isık Atagunduz, Tayfur Toptas

Open source

DOI
10.3390/jcm15166350
Published
2026-08-17
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm15166350,
  title = {Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology},
  author = {Meral Ulukoylu Menguc and Fatma Arikan and Pelin Aytan and Huseyin Saffet Bekoz and Fazıl Cagrı Hunutlu and Fatma Keklik Karadag and Gulcin Miyase Sonmez and Burak Deveci and Fatma Aykac and Ayse Uysal and Bugse Gulec Zengin and Turhan Koksal and Hulya Odluyurt and Deniz Goren and Turgay Ulas and Emel Isleyen and Esra Terzi Demirsoy and Metban Mastanzade and Selin Kucukyurt and Figen Atalay and Esin Oguz Kozan and Sureyya Yigit Kaya and Vildan Ozkocaman and Zehra Aksit Bozkına and Selami Koçak Toprak and Mustafa Cabuk and Volkan Karakus and Umut Yilmaz and Muhlis Cem Ar and Mehmet Sonmez and Melda Comert and Gulsum Ozet and Ozgur Mehtap and Mustafa Nuri Yenerel and Ahmet Kursad Gunes and Ayse Tulin Tuglular and Fahir Ozkalemkas and Güray Saydam and Isık Atagunduz and Tayfur Toptas},
  year = {2026},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm15166350},
  url = {https://doi.org/10.3390/jcm15166350}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology
AU  - Meral Ulukoylu Menguc
AU  - Fatma Arikan
AU  - Pelin Aytan
AU  - Huseyin Saffet Bekoz
AU  - Fazıl Cagrı Hunutlu
AU  - Fatma Keklik Karadag
AU  - Gulcin Miyase Sonmez
AU  - Burak Deveci
AU  - Fatma Aykac
AU  - Ayse Uysal
AU  - Bugse Gulec Zengin
AU  - Turhan Koksal
AU  - Hulya Odluyurt
AU  - Deniz Goren
AU  - Turgay Ulas
AU  - Emel Isleyen
AU  - Esra Terzi Demirsoy
AU  - Metban Mastanzade
AU  - Selin Kucukyurt
AU  - Figen Atalay
AU  - Esin Oguz Kozan
AU  - Sureyya Yigit Kaya
AU  - Vildan Ozkocaman
AU  - Zehra Aksit Bozkına
AU  - Selami Koçak Toprak
AU  - Mustafa Cabuk
AU  - Volkan Karakus
AU  - Umut Yilmaz
AU  - Muhlis Cem Ar
AU  - Mehmet Sonmez
AU  - Melda Comert
AU  - Gulsum Ozet
AU  - Ozgur Mehtap
AU  - Mustafa Nuri Yenerel
AU  - Ahmet Kursad Gunes
AU  - Ayse Tulin Tuglular
AU  - Fahir Ozkalemkas
AU  - Güray Saydam
AU  - Isık Atagunduz
AU  - Tayfur Toptas
PY  - 2026
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15166350
UR  - https://doi.org/10.3390/jcm15166350
ER  - 

APA

Menguc, M. U., Arikan, F., Aytan, P., Bekoz, H. S., Hunutlu, F. C., Karadag, F. K., Sonmez, G. M., Deveci, B., Aykac, F., Uysal, A., Zengin, B. G., Koksal, T., Odluyurt, H., Goren, D., Ulas, T., Isleyen, E., Demirsoy, E. T., Mastanzade, M., Kucukyurt, S., Atalay, F., Kozan, E. O., Kaya, S. Y., Ozkocaman, V., Bozkına, Z. A., Toprak, S. K., Cabuk, M., Karakus, V., Yilmaz, U., Ar, M. C., Sonmez, M., Comert, M., Ozet, G., Mehtap, O., Yenerel, M. N., Gunes, A. K., Tuglular, A. T., Ozkalemkas, F., Saydam, G., Atagunduz, I., & Toptas, T. (2026). Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15166350

Source records